An ad hoc committee will plan and host a public workshop inviting individuals from the FDA, pharmaceutical industry, academia, NIH, and advocacy groups to make presentations and stimulate discussions focused on how best to integrate the current tools for data collection with current methods of data analysis. In addition, the workshop participants will discuss opportunities for potential partnerships with various stakeholders. Specifically, participants will be invited to present and discuss information that will:

• Review available data on the extent to which emergent suicidal ideation predicts the occurrence of actual suicidal behavior particularly in the short-term.
• Ascertain optimal methods of analysis to address if suicidal ideation predicts the short-term occurrence of actual suicidal behavior.
• Examine potential partnerships between the FDA, pharmaceutical industry, academia, and the NIH that could be used to facilitate data-sharing from randomized clinical trials.

An individually authored summary of the workshop will be prepared in accordance with institutional policy and procedures.